DOP067 Treatment discontinuation, flares and hospitalisations among biologic-naïve patients with IBD over the first year of treatment: a comparative effectiveness study of vedolizumab vs. infliximab

Autor:	M Raluy-Callado, A Berger, Javaria Mona Khalid, Haridarshan Patel
Rok vydání:	2018
Předmět:	medicine.medical_specialty business.industry Comparative effectiveness research Gastroenterology General Medicine medicine.disease Inflammatory bowel disease Infliximab Vedolizumab Discontinuation Therapy naive Internal medicine medicine business medicine.drug
Zdroj:	Journal of Crohn's and Colitis. 12:S076-S076
ISSN:	1876-4479 1873-9946
DOI:	10.1093/ecco-jcc/jjx180.104
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::12bd83ca03fa88706689df97b013b97b https://doi.org/10.1093/ecco-jcc/jjx180.104 Zobrazit plný text záznamu